Clicky

Deinove(ALDEI)

Description: DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers PHYT-N-Resist, an anti-aging active ingredient for cosmetics; Luminity, a carotenoid-based ingredient to absorb blue light and exceptional antioxidant properties; HEBELYS, a natural active ingredient produced by fermentation of Sphingomonas; and BIOME Oléoactif, which acts as a post-biotic extract with a prebiotic effect to balance the skin microbiota. In addition, the company develops a process for producing natural ingredients for animal feed. DEINOVE SA has partnership agreements primarily with bioMérieux, Naicons, Medpace, Institut Pasteur, Hallstar Group, Sharon Laboratories, Oléos-Hallstar, Greentech, and Avril. The company was founded in 2006 and is headquartered in Grabels, France.


Keywords: Antibiotics Bacteria Bacteriology Digestive System Gram Positive Bacteria Clostridioides Difficile Prebiotic Microorganisms Biomérieux Clostridiaceae Institut Pasteur

Home Page: www.deinove.com

Cap Sigma
Grabels, 34790
France
Phone: 33 4 48 19 01 00


Officers

Name Title
Dr. Alexis Rideau Chief Exec. Officer
Prof. Miroslav Radman Ph.D. Co-Founder & Member of Scientific Advisory Board
Mr. Mario Alcaraz Chief Financial & Admin. Officer
Dr. Georges Gaudriault Ph.D. Chief Scientific Officer
Ms. Johane Rinaldi Chief HR Officer
Dr. Yannick Pletan M.D. Chief Medical Officer & Independent Director
Mr. Michael Mourez Ph.D. Chief Innovation Officer

Exchange: PA

Country: FR : France

Currency: Euro (€)

GIC Sector: Materials
GIC Group: Materials
GIC Industry: Chemicals
GIC Sub-Industry: Specialty Chemicals
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 4.114
IPO Date:
Fiscal Year End: December
Full Time Employees: 44
Back to stocks